Comparable risk of recurrent ventricular tachyarrhythmias in implantable cardioverter‐defibrillator recipients treated with single beta‐blocker or combined amiodarone-Reference-Cited by-同舟云学术

Comparable risk of recurrent ventricular tachyarrhythmias in implantable cardioverter‐defibrillator recipients treated with single beta‐blocker or combined amiodarone

Published:2020-11-27 Issue:3 Volume:128 Page:493-502
ISSN:1742-7835
Container-title:Basic & Clinical Pharmacology & Toxicology
language:en
Short-container-title:Basic Clin. Pharmacol. Toxicol.

Author:

Schupp Tobias¹^ORCID,Behnes Michael¹^ORCID,Kim Seung‐hyun¹,Müller Julian¹,Weidner Kathrin¹,Reiser Linda¹,Huseynov Aydin¹,Bollow Armin¹,Borggrefe Martin¹,Taton Gabriel¹,Reichelt Thomas¹,Ellguth Dominik¹,Engelke Niko¹,Akin Muharrem²,Große Meininghaus Dirk³,Bertsch Thomas⁴,Akin Ibrahim¹

Affiliation:

1. First Department of Medicine Faculty of Medicine Mannheim University Medical Centre Mannheim (UMM)University of HeidelbergDZHK (German Center for Cardiovascular Research) Partner Site Heidelberg/Mannheim Mannheim Germany

2. Department of Cardiology and Angiology Hannover Medical School Hannover Germany

3. Department of Cardiology Carl‐Thiem‐Klinikum Cottbus Cottbus Germany

4. Institute of Clinical Chemistry Laboratory Medicine and Transfusion Medicine General Hospital NurembergParacelsus Medical University Nuremberg Germany

Publisher

Wiley

Subject

Pharmacology,Toxicology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcpt.13532

Reference26 articles.

1. Strategies to Reduce Recurrent Shocks Due to Ventricular Arrhythmias in Patients with an Implanted Cardioverter-Defibrillator

2. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death

3. Beta-Blockers and ACE Inhibitors Are Associated with Improved Survival Secondary to Ventricular Tachyarrhythmia

4. Anti-arrhythmic medications increase non-cardiac mortality – A meta-analysis of randomized control trials

5. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Amiodarone and β‐blocker combination therapy versus β‐blocker monotherapy for ICD shock prevention: A meta‐analysis;Pacing and Clinical Electrophysiology;2024-06-17

2. Amiodarone for the prevention of shocks and death in patients with implantable cardioverter-defibrillators: Hero or villain?;Heart Rhythm;2023-04

3. Single beta-blocker or combined amiodarone therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy—defibrillator patients: Insights from the German DEVICE registry;Heart Rhythm;2023-04

4. Severe heart failure with rapid arrhythmia: Treatment with amiodarone and esmolol and its effect on TGF-β1, APN and PIIINP;Indian Journal of Experimental Biology;2023

5. Amiodarone;Reactions Weekly;2021-08